Laronidase Completed Phase 3 Trials for Mucopolysaccharidosis Type I (MPS I) / Hurler-Scheie Syndrome / Mucopolysaccharidosis IH Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00912925Clinical Study of Aldurazyme in Patients With Mucopolysaccharidosis (MPS) I